Alvotech (ALVO) Non-Current Debt (2020 - 2026)
Alvotech's (ALVO) quarterly Non-Current Debt came in at $1.3 billion in Q1 2026, up 19.09% YoY from $1.1 billion in Q1 2025, and little changed on a QoQ basis from $1.3 billion in Q4 2025.
Alvotech (ALVO) Non-Current Debt (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Non-Current Debt data on file, last reported at $1.3 billion in Q1 2026.
- Quarterly Non-Current Debt rose 19.09% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 19.09% YoY) and the FY2025 annual result came in at $1.3 billion, up 21.84% from the prior year.
- Non-Current Debt held at $1.3 billion in Q1 2026, from $1.3 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.3 billion in Q1 2026 to a low of $56.9 million in Q2 2024.
- A 5-year average of $889.1 million and a median of $973.3 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2024 — Non-Current Debt slumped 92.77% — and 2025, when it jumped 1785.01%.
- Tracing ALVO's Non-Current Debt over 5 years: stood at $744.7 million in 2022, then rose by 23.83% to $922.1 million in 2023, then rose by 12.34% to $1.0 billion in 2024, then climbed by 21.84% to $1.3 billion in 2025, then climbed by 0.39% to $1.3 billion in 2026.
- The last three Non-Current Debt figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 1.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.01 Bn |
| Jun 30, 2024 | 56.88 Mn |
| Mar 31, 2024 | 940.59 Mn |
| Dec 31, 2023 | 922.13 Mn |
| Jun 30, 2023 | 786.18 Mn |
| Mar 31, 2023 | 770.66 Mn |
| Dec 31, 2022 | 744.65 Mn |
| Jun 30, 2022 | 438.19 Mn |
| Dec 31, 2021 | 398.14 Mn |
| Dec 31, 2020 | 565.40 Mn |